Market revenue in 2023 | USD 530.9 million |
Market revenue in 2030 | USD 707.7 million |
Growth rate | 4.2% (CAGR from 2023 to 2030) |
Largest segment | Pcr-based diagnostics |
Fastest growing segment | NGS DNA Diagnosis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays-based Diagnostics |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna diagnostics market will help companies and investors design strategic landscapes.
Pcr-based diagnostics was the largest segment with a revenue share of 49.84% in 2024. Horizon Databook has segmented the Germany dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
The DNA diagnostics market in Germany is propelled by significant investments in biotechnology and a strong healthcare system that prioritizes early disease detection & personalized treatment approaches. The country’s well-established infrastructure for medical research, along with a high level of public & private funding, fosters innovation in genetic testing technologies.
In addition, increasing public awareness of genetic disorders and the importance of early diagnosis are leading more individuals to seek DNA tests. Germany’s emphasis on preventive healthcare and the integration of genetic testing into standard medical practice contribute to market growth.
In Germany, the increasing rate of tuberculosis is one of the major factors promoting market growth. In Germany, around 4,076 cases of tuberculosis were reported in total in 2022. This is equivalent to 4.9 cases of tuberculosis per 100,000 people annually, according to a Federal Institute article released by the Robert Koch Institute.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany dna diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Germany dna diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account